<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01907191</url>
  </required_header>
  <id_info>
    <org_study_id>13-06-001</org_study_id>
    <nct_id>NCT01907191</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy</brief_title>
  <official_title>Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Francis Care</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Francis Care</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is being undertaken to compare the pain control using either bupivacaine versus
      liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up
      to 72 hours while regular bupivacaine can provide pain relief up to 12 hours
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients undergoing hip arthroscopy experience moderate to severe postoperative pain.
      Effective pain control after surgery is an important component in the overall management of
      these patients. Good pain control encourages early participation in rehabilitation program,
      increases success of the surgery, and improves patient satisfaction. Typically, postoperative
      analgesia is provided to these patients either with nerve blocks or opioid medications. Both
      these methods provide good pain relief but nerve blocks are associated with weakness of lower
      extremity muscles which interferes with early ambulation and increase the risk of falls while
      narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus,
      urinary retention, sedation and respiratory depression.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>96 hours after surgery</time_frame>
    <description>Opioid consumption will be reviewed at 96 hours after surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain Scores</measure>
    <time_frame>96 hours after surgery</time_frame>
    <description>Analysis of pain scores (at rest and ambulation) during hospital stay.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Sleep disturbance</measure>
    <time_frame>96 hours after surgery</time_frame>
    <description>Analysis of sleep disturbance during hospital stay</description>
  </other_outcome>
  <other_outcome>
    <measure>Satisfaction with pain management</measure>
    <time_frame>96 hours after surgery</time_frame>
    <description>Analysis of pain management satisfaction during hospital stay</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Hip Injuries</condition>
  <arm_group>
    <arm_group_label>Liposomal bupivacaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound guided injection of liposomal bupivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine (around the anterior, lateral and medial aspect of hip joint)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>liposomal bupivacaine</intervention_name>
    <description>(Ultrasound guided injection of liposomal bupivacaine)</description>
    <arm_group_label>Liposomal bupivacaine</arm_group_label>
    <other_name>Exparel</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>(around the anterior, lateral and medial aspect of hip joint)</description>
    <arm_group_label>Bupivacaine</arm_group_label>
    <other_name>Marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients having hip arthroscopy

        Exclusion Criteria:

          -  History of neurologic disease, neuropathy, diabetes

          -  Allergy to local anesthetic solution

          -  Chronic use of narcotics

          -  Inability to give consent/cooperate with study

          -  History of previous hip arthroscopy on the ipsilateral side

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjay Sinha, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Francis Hospital and Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sanjay Sinha, MD</last_name>
    <email>sanjaysinha@comcast.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Saint Francis Hospital and Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sanjay Sinha, MD</last_name>
      <email>sanjaysinha@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Sanjay Sinha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2013</study_first_submitted>
  <study_first_submitted_qc>July 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2013</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hip Arthroscopy</keyword>
  <keyword>Liposomal Bupivacaine</keyword>
  <keyword>Bupivacaine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hip Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

